Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Serplulimab”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06911606
What this trial is testing

Study of Serplulimab Plus Chemotherapy as Neoadjuvant Therapy for Limited-stage Small Cell Lung Cancer (LS-SCLC)

Who this might be right for
SCLC, Limited Stage
Guangdong Provincial People's Hospital 45
Testing effectiveness (Phase 2)Looking for participantsNCT07340489
What this trial is testing

Serplulimab for Locally Advanced Cervical Cancer

Who this might be right for
Cervical Cancer
Tianjin Medical University Cancer Institute and Hospital 216
Large-scale testing (Phase 3)Looking for participantsNCT07739758
What this trial is testing

YL201 in Combination With Serplulimab in Participants With Treatment-naïve Extensive-stage Small Cell Lung Cancer

Who this might be right for
SCLC, Extensive Stage
MediLink Therapeutics (Suzhou) Co., Ltd. 442
Not applicableLooking for participantsNCT06128252
What this trial is testing

Clinical Study of Taurine Combined With Neoadjuvant Chemo-Immunotherapy for Treatment of Locally Advanced Gastric Cancer

Who this might be right for
Gastric Cancer
Tang-Du Hospital 96
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07175389
What this trial is testing

JDB153 Combined With Serplulimab for Pancreatic Cancer After Standard Treatment Failure

Who this might be right for
Refractory Pancreatic Ductal AdenocarcinomaRefractory Pancreatic Adenocarcinoma
West China Hospital 10
Testing effectiveness (Phase 2)UnknownNCT06350162
What this trial is testing

Testing the Addition of Radiation Therapy to the Immune Therapy Treatment for ES-SCLC

Who this might be right for
Extensive Stage Lung Small Cell Cancer
Zhejiang Cancer Hospital 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06439550
What this trial is testing

Adjuvant Treatment With Serplulimab，Trastuzumab and SOX in the HER-2 Positive GC/GEJC

Who this might be right for
HER2-positive Gastric Cancer
The First Affiliated Hospital of Zhengzhou University 42
Large-scale testing (Phase 3)Looking for participantsNCT07177443
What this trial is testing

Serplulimab Combined With Induction Chemotherapy and Radiotherapy in Nasopharyngeal Carcinoma

Who this might be right for
Locally Advanced Nasopharyngeal Carcinoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 710
Large-scale testing (Phase 3)Active Not RecruitingNCT05468489
What this trial is testing

To Evaluate Efficacy and Safety of Serplulimab + Chemotherapy (Carboplatin- Etoposide) in US Patients With ES-SCLC

Who this might be right for
Extensive Stage Small Cell Lung Cancer
Shanghai Henlius Biotech 200
Testing effectiveness (Phase 2)Looking for participantsNCT07596121
What this trial is testing

Serplulimab Monotherapy in Elderly Patients With NSCLC and PD-L1 TPS ≥ 50%

Who this might be right for
NSCLC (Non-small Cell Lung Cancer)
Tang-Du Hospital 60
Testing effectiveness (Phase 2)Looking for participantsNCT07253142
What this trial is testing

A Phase II Clinical Study to Evaluate HLX43 in Combination With Serplulimab in Subjects With Advanced Lung Cancer

Who this might be right for
Non Small Cell Lung CancerSmall Cell Lung Cancer
Shanghai Henlius Biotech 120
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07819604
What this trial is testing

Serplulimab Combined With CAPOX and Bevacizumab as Neoadjuvant Therapy for Locally Advanced Colorectal Cancer

Who this might be right for
Locally Advanced Colorectal Cancer
Xijing Hospital 85
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07446049
What this trial is testing

A Single-arm, Open-label, Multicenter, Phase Ib/II Clinical Trial of CVL237 Tablets in Combination With Serplulimab Injection for the Treatment of Advanced Solid Tumors With PTEN Loss or Low Expression

Who this might be right for
Locally Advanced or Metastatic Solid TumorsPTEN Loss or Low Expression
Convalife (Shanghai) Co., Ltd. 180
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07064876
What this trial is testing

Serplulimab Combined With Cryoablation for Early-Stage Non-Small Cell Lung Cancer

Who this might be right for
Early Lung Cancer
Xi Junjie 25
Early research (Phase 1)Looking for participantsNCT06302062
What this trial is testing

Phase I Clinical Study of Tumor-associated Lymph Node T Cell Therapy for Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorTumor Associated Lymph Node T CellImmunotherapy
Guangzhou FineImmune Biotechnology Co., LTD. 23
Testing effectiveness (Phase 2)Looking for participantsNCT07398937
What this trial is testing

Comparison of Serplulimab Versus Nivolumab in Neoadjuvant Therapy for Resectable Stage II-IIIA Squamous NSCLC

Who this might be right for
Resectable Stage II-IIIa Squamous NSCLC
Fudan University 116
Testing effectiveness (Phase 2)Looking for participantsNCT05954429
What this trial is testing

Explore the Third-line Treatment of Fruquintinib Combined With Serplulimab in Advanced Non-liver-limited Metastatic Colorectal Cancer: a Single-center, Phase 2 Study

Who this might be right for
Colorectal Cancer
Fudan University 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT06576921
What this trial is testing

Efficacy and Safety of Serplulimab Combined With Chemotherapy as Neoadjuvant Treatment for Locally Advanced Gastric Cancer or Adenocarcinoma of Esophagogastric Junction

Who this might be right for
Stomach NeoplasmsImmune Checkpoint Inhibitors
Xijing Hospital 116
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07391826
What this trial is testing

Megestrol Acetate Oral Suspension for Cachexia in Patients With cStage III Gastric/Gastroesophageal Junction Adenocarcinoma Receiving Neoadjuvant Therapy With Serplulimab Combined With SOX

Who this might be right for
Stage III Gastric Cancer
The First Affiliated Hospital with Nanjing Medical University 48
Testing effectiveness (Phase 2)Looking for participantsNCT06295926
What this trial is testing

Serplulimab Combined With CCRT for LS-SCLC.

Who this might be right for
Small Cell Lung Cancer
Peking Union Medical College Hospital 96
Next Page